BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li F, Chen Q, Xue H, Zhang L, Wang K, Shen F. LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis. Cell Death Dis 2020;11:894. [PMID: 33093444 DOI: 10.1038/s41419-020-03029-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Barik GK, Sahay O, Behera A, Naik D, Kalita B. Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application. Biochim Biophys Acta Rev Cancer 2021;1876:188612. [PMID: 34391844 DOI: 10.1016/j.bbcan.2021.188612] [Reference Citation Analysis]
2 Chen K, Gan JX, Huang ZP, Liu J, Liu HP. Clinical significance of long noncoding RNA MNX1-AS1 in human cancers: a meta-analysis of cohort studies and bioinformatics analysis based on TCGA datasets. Bioengineered 2021;12:875-85. [PMID: 33685348 DOI: 10.1080/21655979.2021.1888596] [Reference Citation Analysis]
3 Song N, Liu J, Zhang K, Yang J, Cui K, Miao Z, Zhao F, Meng H, Chen L, Chen C, Li Y, Shao M, Su W, Wang H. The LIM Protein AJUBA is a Potential Oncogenic Target and Prognostic Marker in Human Cancer via Pan-Cancer Analysis. Front Cell Dev Biol 2022;10:921897. [DOI: 10.3389/fcell.2022.921897] [Reference Citation Analysis]
4 Wu Y, Hayat K, Hu Y, Yang J. Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma. Front Cell Dev Biol 2022;10:890605. [DOI: 10.3389/fcell.2022.890605] [Reference Citation Analysis]
5 Shen Y, Lv M, Fang Y, Lu J, Wu Y. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis. J Ovarian Res 2021;14:161. [PMID: 34789303 DOI: 10.1186/s13048-021-00910-0] [Reference Citation Analysis]
6 Yuan C, Zhang J, Deng C, Xia Y, Li B, Meng S, Jin X, Cheng L, Li H, Zhang C, He Y. Crosstalk of Histone and RNA Modifications Identified a Stromal-Activated Subtype with Poor Survival and Resistance to Immunotherapy in Gastric Cancer. Front Pharmacol 2022;13:868830. [DOI: 10.3389/fphar.2022.868830] [Reference Citation Analysis]
7 Zhang Y, Wang Y, Ji H, Ding J, Wang K. The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms. J Exp Clin Cancer Res 2022;41:202. [PMID: 35701841 DOI: 10.1186/s13046-022-02403-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lei GL, Li Z, Li YY, Hong ZX, Wang S, Bai ZF, Sun F, Yan J, Yu LX, Yang PH, Yang ZY. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis. Environ Toxicol 2021;36:2322-32. [PMID: 34418280 DOI: 10.1002/tox.23346] [Reference Citation Analysis]
9 Wei X, Wang Y, Ji C, Luan J, Yao L, Zhang X, Wang S, Yao B, Qin C, Song N. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment. Front Genet 2021;12:706661. [PMID: 34712264 DOI: 10.3389/fgene.2021.706661] [Reference Citation Analysis]
10 Zheng Y, Su L, Tan J, Dong F. Actinidia chinensis Planch Root extract suppresses the growth and metastasis of hypopharyngeal carcinoma by inhibiting E2F Transcription Factor 1-mediated MNX1 antisense RNA 1. Bioengineered 2022;13:4911-22. [DOI: 10.1080/21655979.2022.2037226] [Reference Citation Analysis]